EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹7,709 Cr | ₹6,573 Cr | ₹5,947 Cr | ₹6,659 Cr | ₹5,803 Cr |
What is the latest Total Liabilities ratio of EMCURE PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹7,709 Cr |
Mar2023 | ₹6,573 Cr |
Mar2022 | ₹5,947 Cr |
Mar2021 | ₹6,659 Cr |
Mar2020 | ₹5,803 Cr |
How is Total Liabilities of EMCURE PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹7,709 Cr | 17.28 | |
Mar2023 | ₹6,573 Cr | 10.53 | |
Mar2022 | ₹5,947 Cr | -10.69 | |
Mar2021 | ₹6,659 Cr | 14.75 | |
Mar2020 | ₹5,803 Cr | - |
Compare Total Liabilities of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹27,063.4 Cr | 0.3% | 11.4% | 8.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 0.3% |
11.4% |
8.9% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses